What's inside? Savings.

Do you get your Xiidra prescription from a mail-order pharmacy?


XIIDRA Iinsider Program Terms & Conditions:

Limitations apply. Valid for patients with private (commercial) insurance only. The Xiidra Co-pay Card Program includes the Copay Card and rebate. Eligible, commercially-insured patients using the Copay Card pay $0 for their first prescription of Xiidra. $0 first fill available for prescriptions up to 90 days. After the first fill, eligible, commercially-insured patients may pay as little as $0 for prescriptions of Xiidra, subject to a maximum monthly savings of $250 for each 30-day prescription and $750 for each 90-day prescription. Patient is responsible for any costs once monthly savings limit is reached. Program not valid (i) under Medicare, Medicaid, TRICARE, VA, DoD, or any other federal or state health care program, (ii) where patient is not using insurance coverage at all, or (iii) where the patient's insurance plan reimburses for the entire cost of the drug. The value of this program is exclusively for the benefit of patients and is intended to be credited towards patient out-of-pocket obligations and maximums, including applicable co–payments, coinsurance, and deductibles. Program is not valid where prohibited by law. Patient may not seek reimbursement for the value received from this program from other parties, including any health insurance program or plan, flexible spending account, or health care savings account. Patient is responsible for complying with any applicable limitations and requirements of their health plan related to the use of the Program. Valid only in the United States and Puerto Rico. This Program is not health insurance. Program may not be combined with any third-party rebate, coupon, or offer. Proof of purchase may be required. Novartis reserves the right to rescind, revoke, or amend the Program and discontinue support at any time without notice.

XIIDRA, the XIIDRA logo, XIIDRA IINSIDER and ii are registered trademarks of Novartis AG.

All trademarks are the property of their respective owners.

Use of this website is governed by the Terms of Use and Privacy Statement.

Copyright © 2020 Novartis Pharmaceuticals Corporation. All rights reserved.     9/20 T-AAF-1392962